FDA Accepts NDA for Presbyopia Eye Drop BRIMOCHOL PF from Tenpoint Therapeutics
PDUFA date set for January 2026, launch expected first half of year The race to treat presbyopia just picked up…
Opus’ LYNX-2 Phase III Trial Hits Primary Endpoint for Post-LASIK Night Vision Treatment
Opus’ phentolamine eye drops hit the LYNX-2 letter-gain target on mesopic low contrast distance visual acuity. Opus Genetics (North Carolina,…
popular posts
latest posts
